Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

If generative AI could contribute in the slightest to such discoveries—as has been promised since the start of the AI ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Elsewhere, Slovak Academy of Sciences tasked with looking into safety of COVID mRNA vaccines; four Czech soldiers indicted over death of Afghan prisoner; and Polish foreign minister slams Russia for ...

How valuable would it be to a company who manufactures vaccines if they had a product that the government mandated to be used on every animal? Even the chickens in your back yard? What if the bird flu ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

“She’s an example of this emerging face of cancer that's really quite challenging and quite alarming,” Deignan said.